Erythroblastic synartesis associated with lymphoproliferative disorder: There can be more than meets the eye

Clin Immunol. 2022 Mar:236:108951. doi: 10.1016/j.clim.2022.108951. Epub 2022 Feb 5.

Abstract

Erythroblastic synartesis is a rare cause of acquired dyserythropoiesis. Only 9 cases have been previously reported. We hereby report 3 cases of patients diagnosed with erythroblastic synartesis associated with monoclonal immunoglobulin and an overt malignant lymphoid disorder. A different B-cell clone may produce the monoclonal immunoglobulin, forming a biclonal disorder. In light of these data and literature review, treatment targeting the paraprotein seems to be efficient to control synartesis and correct anemia. In the case of monoclonal gammapathy associated with chronic lymphocytic leukemia, therapeutics should be adapted to control both chronic lymphocytic leukemia and monitored monoclonal immunoglobulin titer.

Keywords: Dyserythropoietic anemia; Lymphoproliferative diseases; Monoclonal gammopathy; Reticulocytopenia; Synartesis.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Antibodies, Monoclonal
  • Erythroblasts / pathology
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell* / pathology
  • Lymphoproliferative Disorders* / complications
  • Paraproteinemias* / complications

Substances

  • Antibodies, Monoclonal